The RAND Forecasting Initiative (RFI) has released a new forecasting topic to examine the policy and security implications of “mirror life,” an emerging area of biotechnology that has prompted both scientific interest and calls for caution.
The new set of forecasting questions supports a RAND Meselson Center research effort to identify key scientific milestones on the pathway to creating mirror life. The insights generated will inform strategies to mitigate the potential risks associated with this technology. We invite forecasters to contribute their perspectives to this important and timely discussion.
What is mirror life? Why explore this now?
Mirror life refers to hypothetical forms of life engineered so that their molecular building blocks are the mirror image of those found in all known life on Earth. In chemistry, many biological molecules exist in two “chiral” forms, like left and right hands: they are similar but not interchangeable. All natural life uses one set of these forms, while mirror life would use the opposite set.
Because of this difference, natural immune systems might not recognize mirror organisms, specifically mirror bacteria. Their molecules simply would not match the shapes these systems are designed to detect, allowing mirror bacteria to become pathogens able to infect humans, other animals, and plants. In addition, mirror bacteria released into the environment could act like an invasive species, causing ecosystems to collapse at an unprecedented scale. It may also be challenging to produce countermeasures at the scale necessary to prevent these risks. This potential for immune evasion and environmental damage raises important biosecurity and policy concerns.
Although some researchers have discussed possible benefits of mirror molecules (precursors on the pathway to mirror life creation), such as drugs that are resistant to degradation in the human body, the scientific consensus is shifting toward the view that the risks of creating mirror life itself outweigh any perceived and potential benefit. It is worth noting that this view doesn’t extend to work on mirror molecules.
Leading scientific voices have called for a pause or moratorium on mirror life research until clearer guidelines and oversight can be established. There is an opportunity to consider and preempt risks before they are realized as the capability to create mirror life is likely at least a decade away and would require major investments and technical breakthroughs.
Given these risks and uncertainties of potential benefits, the RAND Meselson Center project is working to clarify scientific milestones, regulatory options, and monitoring strategies for mirror life. Your forecasts will directly inform RAND’s research for policymakers, government funders, international organizations, and the US intelligence community. The project’s outcomes will help:
- Map likely technical and economic pathways to mirror life as well as their bottlenecks;
- Assess how regulatory interventions could alter these pathways and associated risks; and
- Support future RAND work on policy recommendations and strategies for monitoring mirror life research.
Additional research for forecasters
To help with your forecasting, below are some recommendations from the RFI team:
- Technical report on mirror life pathways:
KP Adamala et al, Technical Report on Mirror Bacteria: Feasibility and Risks - Recent scientific commentary on mirror life research:
Confronting risks of mirror life – Science (2024)
University of Utah Health: Mirror Life is Still a Hypothetical
Harvard Magazine: Biology’s “Mirror Organisms”—And Their Dangers (2025) - Policy and risk reports:
UK Government Expert Note on Mirror Life (2025) - Proceedings from the Mirror Biology Dialogues Fund (MBDF):
Official site for upcoming international meetings and updates: mbdialogues.org
Contribute your forecasts
Here are two questions to get you started on this topic:
- Will any major international non-governmental research funders implement specific policies restricting or requiring oversight of mirror biology research by 31 December 2030?
- Will government agencies in the U.S., EU, or UK classify mirror biology research under dual-use oversight mechanisms by 31 December 2030?
See the full list of questions on RFI (under the tag: “mirror life”).